New York Genome Center - A Nonprofit Academic Research Institution

News

Rutgers Cancer Institute of New Jersey Becomes 20th Member Institution of the New York Genome Center

The Washington Post and the BBC Interview Dr. Neville Sanjana On His Lab’s Coronavirus Mutation Research

C2i Genomics Raises $12 Million in Series A Funding

C2i Genomics’ innovative breakthrough tumor pattern recognition approach for liquid biopsy is based on research performed in the lab of New York Genome Center Core Faculty Member Dan Landau, MD, PhD, who holds a joint appointment at Weill Cornell Medicine.

NYS DOH Partnering with the NYGC and Rockefeller University on Genome Study to Understand COVID-19 Related Illnesses in Children

Simons Foundation Annual Report Features Collaborative ALS Study with the NYGC’s Center for Genomics of Neurodegenerative Disease

Ultra-Sensitive Blood Test for Tumor DNA Could Help Monitor Residual Cancer

01 / 02

Publications & Pre-Prints

All Publications

bioRxiv. 2020 July 7.

The D614G mutation in SARS-CoV-2 Spike increases transduction of multiple human cell types.

Zharko Daniloski, Tristan X. Jordan, Juliana Ilmain, Xinyi Guo, Gira Bhabha, Benjamin tenOever, Neville E Sanjana

bioRxiv. 2020 June 28.

Characterizing the molecular regulation of inhibitory immune checkpoints with multi-modal single-cell screens.

Efthymia Papalexi, Eleni Mimitou, Andrew W. Butler, Samantha Foster, Bernadette Bracken, William M. Mauck, View Hans-Hermann Wessels, Bertrand Z. Yeung, Peter Smibert, Rahul Satija

bioRxiv. 2020 June 20.

Phenome-scale causal network discovery with bidirectional mediated Mendelian randomization.

Brielin C Brown, David A Knowles

Faculty labs

NYGC Labs